147 related articles for article (PubMed ID: 22550162)
1. Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.
McBride A; Antonia SJ; Haura EB; Goetz D
J Pharm Pract; 2012 Aug; 25(4):477-85. PubMed ID: 22550162
[TBL] [Abstract][Full Text] [Related]
2. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions].
Cózar Olmo JA; Martínez Colmenero C; Peláez Pleguezuelos I; Leiva Gea I; López García AB; de la Cruz Moreno J
An Pediatr (Barc); 2009 Sep; 71(3):230-4. PubMed ID: 19617010
[TBL] [Abstract][Full Text] [Related]
3. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Nowicki TS; Bjornard K; Kudlowitz D; Sandoval C; Jayabose S
J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789
[TBL] [Abstract][Full Text] [Related]
4. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
Tuffaha HW; Al Omar S
J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
[TBL] [Abstract][Full Text] [Related]
5. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
[TBL] [Abstract][Full Text] [Related]
6. Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.
Vilay AM; Mueller BA; Haines H; Alten JA; Askenazi DJ
Pharmacotherapy; 2010 Jan; 30(1):111. PubMed ID: 20030480
[TBL] [Abstract][Full Text] [Related]
7. Solar burn reactivation induced by methotrexate.
DeVore KJ
Pharmacotherapy; 2010 Apr; 30(4):123e-6e. PubMed ID: 20334462
[TBL] [Abstract][Full Text] [Related]
8. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
[TBL] [Abstract][Full Text] [Related]
9. Effective removal of methotrexate by high-flux hemodialysis.
Saland JM; Leavey PJ; Bash RO; Hansch E; Arbus GS; Quigley R
Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
[TBL] [Abstract][Full Text] [Related]
10. Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use.
Snyder RL
Am J Health Syst Pharm; 2007 Jun; 64(11):1163-9. PubMed ID: 17519458
[TBL] [Abstract][Full Text] [Related]
11. Low-dose carboxypeptidase-G2 for methotrexate toxicity in a child.
Qudsi R; Abdulhadi O; Sultan I
Pediatr Blood Cancer; 2010 Dec; 55(7):1439-40. PubMed ID: 20981700
[No Abstract] [Full Text] [Related]
12. Potential interaction between methotrexate and omeprazole.
Beorlegui B; Aldaz A; Ortega A; Aquerreta I; Sierrasesúmega L; Giráldez J
Ann Pharmacother; 2000 Sep; 34(9):1024-7. PubMed ID: 10981249
[TBL] [Abstract][Full Text] [Related]
13. Optimal management of methotrexate intoxication in a child with osteosarcoma.
Peyriere H; Cociglio M; Margueritte G; Vallat C; Blayac JP; Hillaire-Buys D
Ann Pharmacother; 2004 Mar; 38(3):422-7. PubMed ID: 14970366
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole-induced exfoliative dermatitis.
Rebuck JA; Rybak MJ; Ramos DP; Weingarten CM
Pharmacotherapy; 1998; 18(4):877-9. PubMed ID: 9692668
[TBL] [Abstract][Full Text] [Related]
15. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels.
Wyatt KD; Cooper J; Scott K; Broomall E; Altaf S; Hogan MC; Rodriguez V; Khan S
J Pediatr Hematol Oncol; 2018 Mar; 40(2):152-155. PubMed ID: 29240024
[TBL] [Abstract][Full Text] [Related]
16. What is the best therapy for toxicity in the setting of methotrexate-associated acute kidney injury: high-flux hemodialysis or carboxypeptidase G2?
Kumar N; Shirali AC
Semin Dial; 2014; 27(3):226-8. PubMed ID: 24620824
[No Abstract] [Full Text] [Related]
17. Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors.
Santucci R; Levêque D; Kemmel V; Lutz P; Gérout AC; N'guyen A; Lescoute A; Schneider F; Bergerat JP; Herbrecht R
Anticancer Res; 2010 Mar; 30(3):963-5. PubMed ID: 20393020
[TBL] [Abstract][Full Text] [Related]
18. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO
Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular methotrexate-induced aseptic meningitis.
Hawboldt J; Bader M
Ann Pharmacother; 2007 Nov; 41(11):1906-11. PubMed ID: 17878395
[TBL] [Abstract][Full Text] [Related]
20. Preventing and Managing Toxicities of High-Dose Methotrexate.
Howard SC; McCormick J; Pui CH; Buddington RK; Harvey RD
Oncologist; 2016 Dec; 21(12):1471-1482. PubMed ID: 27496039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]